Please assess the completion status of the following clinical trial:

Trial Title: Alginate-based Reflux Suppressant and Magnesium-aluminium Antacid Gel for Treatment of Heartburn in Pregnancy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Pregnant women gestational age less than 36 weeks with heartburn~Exclusion Criteria:~* Having medical disease that contraindicated to use study drug~* Allergic to alginate-based reflux suppressant and magnesium-aluminium antacid gel

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 40 Years
- Healthy Volunteers: t

Study Arms:
- Alginate-based reflux suppressant (Type: ACTIVE_COMPARATOR): Alginate-based reflux suppressant 15 ml oral every 6 hours for 2 weeks
- magnesium-aluminium antacid gel (Type: SHAM_COMPARATOR): magnesium-aluminium antacid gel 15 ml oral every 6 hours for 2 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).